Obese postmenopausal women typically have altered serum levels of metabolic hormones, such as insulin, insulin-like growth factor (IGF)-1, leptin, resistin and adiponectin, and are at increased risk for developing breast cancer [2], [3], [4]. This evidence concerns the gene LEP and breast cancer.